Fragmented Operations & Regulatory Burden
Clinical trials are among the most operationally complex processes in modern medicine. Pharmaceutical sponsors, site investigators, and patients often work across fragmented systems — paper-based consent forms, manual CRF entry, disconnected patient communication channels, and no unified audit trail.
The regulatory burden (FDA 21 CFR Part 11, HIPAA, ICH-GCP) further compounded every technical decision. Without automated audit trails, immutable e-signatures, and role-based PHI controls, passing FDA and GCP audits relied heavily on manual documentation. Furthermore, decentralized trial models were impossible, limiting trial reach and increasing patient dropout rates.
End-to-End Trial Lifecycle Platform
Lifecycle Management
Sponsor registration, study & site setup, subject enrollment, visit scheduling, ePRO/eCOA diaries, eCRF data capture, drug supply, eTMF — all in one governed platform.
Electronic Consent
eConsent module with video recording, digital signatures, and time-stamped audit events satisfying 21 CFR Part 11 and ICH-GCP requirements.
IoT & Wearable Integration
Integrated seven health device platforms (Fitbit, Oura, Apple Watch, Dexcom CGM, Withings, ActiGraph, Circul) via OAuth2 and REST APIs into BigQuery.
Decentralized Trials
VideoSDK-powered in-app consultations enabled fully remote trial participation, unlocking decentralized clinical trial (DCT) models without site visits.
Director of Engineering & Architect
- Led the architecture, engineering, and delivery of the entire 34-module platform.
- Translated complex clinical trial workflows and regulatory requirements into technical systems design.
- Owned the system architecture document (SADD) and drove technology stack decisions.
- Managed distributed cross-functional teams across parallel workstreams.
- Collaborated directly with pharmaceutical sponsors, clinical operations directors, and regulatory leads.
- Established CI/CD pipelines, code review standards, and SOPs to ensure audit-readiness and engineering predictability.
- Led third-party compliance audits and maintained documentation governance throughout.
Technologies Used
Measurable Results
- Enabled pharmaceutical sponsors to run fully decentralized clinical trials (DCT) — removing geographic barriers.
- Eliminated paper-based CRF and consent processes, reducing transcription errors and accelerating data review.
- Passed third-party regulatory audits with zero critical findings, thanks to compliance-by-design architecture.
- Continuous patient health metrics captured in real time via wearable integrations, enriching outcome data.
- Multi-country deployment supported through language management and configurable study protocols.